1. Home
  2. |Insights
  3. |Third Thursday Webinar - Employees and Marijuana – Legal Updates and Guidance

Third Thursday Webinar - Employees and Marijuana – Legal Updates and Guidance

Webinar | 12.20.18, 7:00 AM EST - 8:00 AM EST

Please join us for the next edition of Third Thursday – Crowell & Moring’s Labor and Employment Update, a webinar series dedicated to helping our clients stay on top of developing law and emerging compliance issues.
In the November elections, three more states legalized either medical or recreational marijuana use. As a result, 33 states now have legalized medical marijuana and 10 have fully legalized recreational marijuana. This trend presents a conundrum for employers, because marijuana continues to be illegal under the federal Controlled Substances Act.


Employers (as well as courts and regulators) continue to struggle with how to handle various implications of legalization. In particular, employers are assessing the merits of their existing drug policies and mandatory drug testing programs, especially when weighed against concerns about employee retention and morale. Legalization of medical marijuana raises tricky compliance questions under federal and state disability protection statutes. And changing public attitudes towards marijuana use can present employers with difficult hiring and retention issues.


Our webinar will explore the recent changes in state laws, and several recent court decisions, regarding legalized marijuana, employment rights of marijuana users, and disability discrimination claims. We will also discuss risk mitigation strategies and best practices for employers in this area.


For more information, please visit these areas: Litigation and Trial, Labor and Employment

Contact

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...